CD8A and neoplasm: It showed that adoptive transfer of STZ-non-diabetic P14 CD8+ effector cells caused a prolonged survival from 36% (8/22 mice of STZ-diabetic group) to 71% (15/21 mice of STZ-non-diabetic group) of tumor-bearing mice on 30 days after tumor inoculation (Figure 3B, p<0.01).